New Protocol: Trastuzumab deruxtecan for her2-positive gastric cancer
|New Protocol: Trastuzumab deruxtecan for her2-positive gastric cancer|
• Open-label, randomized phase II trial (DESTINY-Gastric01)
N Engl J Med 2020;382:2419.
Reviewed by Ulas Darda Bayraktar, MD on Feb 6, 2021
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.